“It is … of all-trans retinoic acid (ATRA) …, or mitoxantrone , 7 ara-C produces long-term remissions in 90% of patients who present with WBC counts o10 000/ml, but …% of patients with initial WBC counts 410 000/ml; the latter patients accordingly are referred to as ‘high risk’.”